Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 158 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Retifanlimab Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over Standard Therapy in Patients with HR-positive, HER2-positive MBC FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma MOST POPULAR Women in Science: Celebrating with our Women of Influence initiative March 15, 2023 After Battling Breast Cancer and Infertility, Mom Welcomes Miracle Baby November 25, 2020 Switching to Camizestrant While Continuing a CDK4/6 Inhibitor After ESR1 Mutation... July 9, 2025 Larger NGS Gene Panel Linked to More Clinical Utility October 16, 2020 Load more HOT NEWS EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab NRG1 Fusion–positive Lung Cancers are Molecularly, Pathologically, and Clinically More Heterogeneous... Helping Kids Cope With Cancer: “Your Stories” Podcast Exploring Coping Resources to Help with Physical, Practical, and Emotional Challenges...
